Mineralys Therapeutics, Inc. (MLYS)
15.33
+0.09
(+0.59%)
USD |
NASDAQ |
Nov 06, 16:00
15.34
+0.01
(+0.07%)
After-Hours: 20:00
Mineralys Therapeutics EPS Diluted (Quarterly) : -0.6442 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.6442 |
| June 30, 2026 | -2.845 |
| March 31, 2026 | -0.4749 |
| December 31, 2025 | -0.4002 |
| September 30, 2025 | -0.5232 |
| June 30, 2025 | -0.6612 |
| March 31, 2025 | -0.794 |
| December 31, 2024 | -0.9797 |
| September 30, 2024 | -1.131 |
| June 30, 2024 | -0.831 |
| Date | Value |
|---|---|
| March 31, 2024 | -0.7017 |
| December 31, 2023 | -0.6083 |
| September 30, 2023 | -0.5537 |
| June 30, 2023 | -0.2972 |
| March 31, 2023 | -0.3086 |
| December 31, 2022 | -0.2221 |
| September 30, 2022 | -0.1635 |
| June 30, 2022 | -0.1586 |
| March 31, 2022 | -0.1853 |
| December 31, 2021 | -0.1205 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Oncolytics Biotech, Inc. | -0.0788 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| Sarepta Therapeutics, Inc. | -0.2687 |
| Anixa Biosciences, Inc. | -0.0762 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -57.33M |
| Total Expenses (Quarterly) | 57.33M |
| Enterprise Value | 830.77M |
| Earnings Yield | -28.47% |
| Normalized Earnings Yield | -28.47 |